Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer (CARDAPAC)
Impact of Physical Activity Intervention on Myocardial Function in Patients With HER2 + Breast Cancer, During Treatment With Trastuzumab in Adjuvant
Sponsor: Centre Hospitalier Universitaire de Besancon
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Centre Hospitalier Universitaire de Besancon
- Metastatic Colorectal Cancer · Phase PHASE2 · Nov 2024
- Gallstone · Phase NA · Sep 2024
- Children, Only · Phase NA · Apr 2024
- Mandibular Dysfunction · Phase NA · Feb 2024
- Metastatic Pancreatic Adenocarcinoma · Phase PHASE2 · Feb 2024
See all terminations from Centre Hospitalier Universitaire de Besancon
A NA clinical study on Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by Centre Hospitalier Universitaire de Besancon and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated
▶ Show 3 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status NA
-
May 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — May 2018 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Besancon
- Ligue contre le cancer, France
- University of Franche-Comté
For direct contact, visit the study record on ClinicalTrials.gov .